ROSANNE ZERINGUE: Open Payments
NPI 1437506979 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,103 in 39 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $492 · 2025 $4,103
Food & beverage: $2,735Travel & lodging: $1,368
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 23 | $2,822 |
| Actelion Pharmaceuticals US, Inc. | 3 | $288 |
| GENZYME CORPORATION | 2 | $235 |
| Dexcom, Inc. | 1 | $163 |
| SCPHARMACEUTICALS INC. | 1 | $126 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $121 |
| ABBVIE INC. | 1 | $97 |
| Merck Sharp & Dohme LLC | 4 | $90 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
Products named: CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, UPTRAVI, DUPIXENT, DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, FUROSCIX, WAINUA.
Industry payments across LA — which companies pay providers there.
